#Amgen

All articles tagged with "Amgen"

Drugmakers Say Medicare Price Negotiations Are Now Showing Up in Sales

Amgen and AbbVie say the first negotiated Medicare drug prices under the Inflation Reduction Act are now affecting business results, offering an early view into how the policy is changing the market.

Key Takeaways

The first negotiated IRA drug prices took effect in January.
Amgen and AbbVie say the policy affected first-quarter sales.

DT Editorial Team·May 6, 2026·via endpoints.news

Amgen Moves to Update Tavneos Label as FDA Pressure Intensifies

Amgen has filed a supplement to update the Tavneos label with additional warning information as the FDA continues pushing to withdraw the drug.

Key Takeaways

Amgen filed a supplement to add more information to Tavneos warning language.
The filing comes amid an ongoing dispute with the FDA.

DT Editorial Team·May 2, 2026·via endpoints.news

FDA Tests a New Regulatory Model With Real-Time Clinical Trial Data

The FDA has launched a pilot to review clinical trial data as it is generated, giving agency scientists earlier access to information from ongoing studies.

Key Takeaways

The FDA is launching a pilot to collect and review clinical trial data in real time.
AstraZeneca and Amgen are the first companies participating in the program.

DT Editorial Team·Apr 28, 2026·via endpoints.news

Amgen CTO David Reese to Retire at End of June

Amgen says longtime executive David Reese, who currently serves as chief technology officer, will retire at the end of June, marking a leadership change inside one of biotech’s largest companies.

Key Takeaways

Amgen says chief technology officer David Reese will retire at the end of June.
Endpoints reports Reese is a longtime Amgen leader and is 63.

DT Editorial Team·Apr 23, 2026·via endpoints.news